COVID-19 inpatients do not gain from aspirin and rivaroxaban combined or colchicine alone | CredoWeb

Artículo

COVID-19 inpatients do not gain from aspirin and rivaroxaban combined or colchicine alone

COVID-19 inpatients do not gain from aspirin and rivaroxaban combined or colchicine alone

Esta publicación es para usuarios registrados

Please register or log in with your account to read the full publication.

Cardiología COVID-19

Cardiovascular Pharmacotherapy

Compartir:

Comentarios

Ver otras publicaciones de este autor

How to avoid heart damage in women receiving breast cancer treatment

Study reports on switch to newer anticoagulants in frail elderly with atrial fibrillation

Ver todas las publicaciones del autor